Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Reexamination Certificate
2004-09-09
2010-10-26
Wax, Robert A (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
Reexamination Certificate
active
07820200
ABSTRACT:
The invention relates to a substained release form of hydralazine for use in cancer therapy. The substained release form of hydralazine can be used to obtain a constant concentration of the active principle in the blood, thereby enabling the demethylating effect of the hydralazine without producing the hypotensive action thereof, such that the inventive composition can be used in cancer therapy.
REFERENCES:
patent: 4521402 (1985-06-01), Dunn
patent: 4606909 (1986-08-01), Bechgaard et al.
patent: 4952402 (1990-08-01), Sparks et al.
Betancourt Alejandro Mohar
Flores Luis Estrada
García Arturo Borbolla
González Alfonso Dueñas
Hernández Alfredo Rivera
Palenik Jeffrey T
Reinhart Boerner Van Deuren P.C.
Wax Robert A
LandOfFree
Pharmaceutical composition for the sustained release of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition for the sustained release of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition for the sustained release of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4213070